Abstract. Transforming growth factor-ß (TGF-ß)-Smad signaling pathway participates in the regulation of a variety of cellular activities. Unlike the high incidences of Smad4 mutation or deletion in pancreatic cancer and gastrointestinal cancers, Smad4 gene is seldom mutated or deleted in hepatocellular carcinoma (HCC). The role of TGF-ß-Smad4 signaling pathway in leading to carcinogenesis of liver cells remains unknown. In this study, we succeeded in silencing Smad4 using lentiviral-mediated Smad4 RNA interference (RNAi). We investigated the role of Smad4 in TGF-ß1-induced cell proliferation and apoptosis of HCC cell line SMMC-7721. We determined cell proliferation, apoptosis, and expression of p21, p16, p53 and caspase 3. Results showed that TGF-ß1 not only had a significant anti-proliferation effect but also induced cellular apoptosis in SMMC-7721 cells. These effects induced by TGF-ß1 were almost completely blocked by the knockdown of Smad4. Western blot analysis revealed that p16 was up-regulated and caspase 3 was activated by silencing of Smad4, and the expression of p21 and wild-type p53 were not affected. These results suggest that TGF-ß1-induced cell growth inhibition by up-regulating p16 expression and cellular apoptosis by activating caspase 3 was Smad4-dependent. Additionally, the knock down of a specific gene using lentiviral-mediated RNAi appears to be a promising tool and strategy for analyzing endogenous gene function.
Introduction
Transforming growth factor (TGF) ßs are polypeptides that regulate several cellular functions, including cell growth and differentiation, motility, extra cellular matrix production, and immune functions (1) (2) (3) (4) . TGF-ßs have three mammalian isoforms, TGF-ß1, -ß2 and -ß3 each with distinct functions in vivo. All three TGF-ßs use the same receptor signaling system. TGF-ß has three receptors, type I (RI), type II (RII) and type III (RIII), RIII (also called ß glycan) binds two TGF-ß polypeptides and recruits TGF-ß to RII and intensifies the TGF-ß signaling pathway (1) (2) (3) (4) (5) . TGF-ß binding to RII stimulates recruitment and transphosphorylation of RI. RI, in turn, phosphorylates Smad2 and 3, which form an oligomeric complex with the Smad4 protein. Smad4 has a central role in the process of TGF-ß1 signaling pathway (1) (2) (3) (5) (6) (7) . Deregulation of TGF-ß expression or signaling has been implicated in the pathogenesis of a variety of diseases, including cancer and fibrosis.
There is growing evidence that in the later stages of cancer development TGF-ß is actively secreted by tumor cells and does not merely act as a bystander but rather contributes to cell growth, invasion, and metastasis and decreases host-tumor immune responses cell. Studies have suggested that TGF-ß1 may be a useful serologic and urinary marker in detecting HCC (8) (9) (10) . Moreover, TGF-ß1 was overexpressed in HCC (11) (12) (13) , the expression level of TGF-ß1 was correlated with the histological differentiation in HCC tissue (13) . The evidence proves that TGF-ß1 plays an important role in HCC. Elucidation of alteration of TGF-ß1 signaling will help in further understanding the molecular mechanisms of hepatocarcinogenesis. Many investigations have revealed that the major factors of TGF-ß1-Smad4 signaling pathway, such as receptors and Smad proteins, function in gastro- (14) . Therefore, the roles of TGF-ß1-Smad4 signaling pathway in HCC need further study.
In the present study, we investigated the function of TGF-ß1-Smad4 signaling pathway in SMMC-7721 cells. We applied lentiviral-mediated Smad4 RNAi to knockdown Smad4 expression. We observed the effects of TGF-ß1 on the cell growth and apoptosis. Then, we examined the role of p16, 21, 53 and caspase 3 in the effects of TGF-ß1. Our results demonstrated that TGF-ß1-induced cell growth inhibition by up-regulating the expression of p16 and cellular apoptosis by activating caspase 3 in a Smad4-dependent manner.
Materials and methods
Cell culture. Human hepatocellular carcinoma cell line SMMC-7721 (purchased from the Institute of Biochemistry and Cell Research, China Life Science Academy, Shanghai, China) was cultured in DMEM supplemented with 10% fetal bovine serum (containing 100 U/ml of penicillin and streptomycin, respectively) at 37˚C in a humidified atmosphere of 5% of CO 2 . Exponentially growing cells were used for the experiments. The cells were treated with TGF-ß1 (Sigma, MO) at the concentration of 100 ng/ml.
Design and cloning of lentiviral shRNA vectors. The target siRNAs against human Smad4 (GenBank, gi: 34147555) for RNAi were designed as: siRNA1: 5'-GCACAAGGTTGGTT GCTAA-3', siRNA2: 5'-CCAGCTACTTACCATCATA-3', siRNA3: 5'-GTACTTCATACCATGCCGA-3', Control sequence of RNAi: 5'-TTCTCCGAACGTGTCACGT-3'. The siRNA3 was the published sequence designed by Jazag et al (6) . In our previous study, we confirmed that siRNA3 was the optimal target siRNA in the above 3 sequences (22) . Lentiviral vector system was purchased from Tronolab (http://tronolab.com/lentivectors.php). This vector system including 3 plasmids: pLVTHM vector, pCMV-dR8.74 and pMD2G. The targeting sequence was subcloned into the pLVTHM vector, which contained H1 promoter and green fluorescent protein (GFP). The resulting lentiviral vector containing Smad4 shRNA was named RNAi-Smad4, and the sequence was confirmed by PCR and sequencing. Lentiviral vector containing negative control sequence of Smad4 shRNA (RNAi-NC) containing the non-silencing sequence was used as infection control.
Lentiviral vector production and cell infection. Lentiviral vectors were produced by transient transfection of HEK293 cells according to standard protocol. HEK293 cell line was supplemented with 10% fetal calf serum and, when subconfluent, transfected with 1800 μl DNA solution: 20 μg LVshSmad4, 15 μg pCMV-dR8.74 and 7.5 μg pMD2G. All virus stocks were produced by calcium phosphate-mediated transfection. After 48 h post-transfection cell supernatants, containing viral particles, were filtered using 0.45 μm Steriflip vacuum filtration system (Millipore) and concentrated by ultracentrifugation at 25,000 rpm at 4˚C. The titer of virus was tested according to the expression level of GFP. The day before infection the SMMC-7721 cells were seeded on dishes with the conference of 30-40%. On the day of infection the SMMC-721 cells were infected by packaged lentiviral production. The parallel SMMC-721 cells without infection were observed at the same time. Cells were cultured in normal growth medium for 72 h after infection. RNAi-NC as infection control was performed as above.
Cell growth analysis. The cellular growth was evaluated by MTT colorimetric assay. Briefly, the cells were thoroughly washed with PBS and then seeded in a 96-well plate (2x10 4 cells/well). After 24 h, 20 μl of MTT solution (1 mg/ml) was added to each well and mixed with the cells. Four hours later, 150 μl of DMSO was added into each well and incubated with the cells for 10 min. Then optical density at 490 nm was determined using an ELISA reader (Bio-TEK Instruments, USA). The TGF-ß1 stimulation of dose-and time-dependent effects was determined.
Cell apoptosis analysis. Cell apoptosis was assayed with terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay and propidium iodide (PI) staining. TUNEL assay was performed using a kit (Roche, USA) according to manufacturer's instructions. Briefly, DNA ends were tagged with fluorescein-labled dUTP using terminal deoxynucleotidyl transferase by incubating the samples at 37 ˚C in a humidified chamber. Cells after treatment with TGF-ß1 for 36 h were washed with PBS, fixed with 2% paraformaldehyde. The slides with cells were then washed 3 times in distilled water, immersed in penetration liquid and incubated on ice for 2 min. Then the slides were washed 3 times in PBS, and 3% H 2 O 2 was added into the chamber for 30 min at room temperature. The slides were rinsed twice in PBS, immersed in TdT reaction liquid, incubated for 30 min at 37˚C, washed in PBS for 5 min, and rinsed in distilled water for 30 sec. Then slides were dealt with prolong anti-fade reagent kit. Morphologic changes were observed under fluorescent microscopy. Sections were also stained with PI to label DNA in the sample. Blue excitation was used to assess the orange-red PI fluorescence. Fluorescence images were taken using Kodak Gold 1000 ASA color film with automatic exposure. Positively stained cells obtained by the respective apoptosis assay were quantified. At least 300 cells were counted for each slide in 5 random fields.
Western blot analysis. Samples of cell extracts were homogenized in SDS-PAGE sample buffer containing 2% SDS. After being heated at 80˚C for 5 min and clarified by spinning in a microcentrifuge at 12,000 rpm and room temperature for 5 min, the total protein extracts were resolved by polyacrylamide gel using the Laemmli buffer system. The resulting gels were stained with Coomassie Blue R-250 to reveal the resolved protein bands. Gels were electrically transferred to nitrocellulose membranes. After blocking in TBS containing 5% non-fat-milk, the membranes were incubated with mouse monoclonal antibody against caspase 3 (Santa Cruz) (1:1000 in TBS containing 5% non-fat milk), and rabbit polyclonal antibodies against Smad4 (Upstate) (1:1000), p16 (Cell Signaling) (1:1000), p21 (Cell Signaling) (1:1000), wild-type p53 (Santa Cruz) (1:1000), and ß-actin (Bost, P.R. China) (1:2000) . The membranes were then washed with TBS containing 0.05% Tween-20, and incubated with peroxidase-conjugated anti-mouse or anti-rabbit IgG secondary antibody (Sigma) (1: 2000) and washed again. The blots were developed in ECL substrate solution (Sigma) to reveal the immunoreactive bands. The protein expression was analyzed by Bandscan software and normalized by the quantity of ß-actin in the same membrane.
Statistical analysis. Statistical analysis was performed using SPSS 11.0. Data were expressed as mean ± SD. One-way analysis of variance (ANOVA) followed by LSD-test was used to assess significant differences among groups. Two independent samples test was used to assess the differences between 2 groups. Differences were considered significant at P<0.05.
Results

Inhibition of Smad4 expression by RNA interference.
In an initial study (22) we designed the siRNAs against human Smad4 and described the validation of the effective targeting site, these were used in the present study. We now performed Smad4 knockdown of SMMC-7721 cells by lentiviralmediated RNAi. As shown in Fig.1A , infection efficiency of lentiviral RNAi vectors of Smad4 (RNAi-Smad4) and the negative control (RNAi-NC) in SMMC-7721 cells was >85%. No significant inhibition on protein expression of Smad4 was observed in cells infected with RNAi-NC. However, Smad4 was knocked down significantly by the infection with RNAiSmad4 (Fig. 1B) . These results indicated that lentiviralmediated RNAi could effectively inhibit Smad4 expression.
Lentiviral-mediated Smad4 RNAi induced anti-proliferation of SMMC-7721 cells.
We examined the cell growth of SMMC-7721 cells infected by RNAi-Smad4 and non-specific control oligonucleotides (RNAi-NC). The TGF-ß1 stimulation of time-dependent effect determined that the inhibition effect was enhanced with prolonged exposure time with TGF-ß1 stimulation (detailed data and figures not shown). We further measured and displayed the cell growth of SMMC-7721 cells with 72 h-TGF-ß1 stimulation. As shown in the cell growth was repressed by RNAi-Smad4 when SMMC-7721 cells were stimulated with or without TGF-ß1 stimulation, respectively (Fig. 2) .
Role of lentiviral-mediated Smad4
RNAi on the expression of p16 and p21. To investigate the mechanism that Smad4 represses TGF-ß1-induced growth inhibition of SMMC-7721 cells, we studied the expression of p16 and 21 (Fig. 3) . The protein p16 was highly expressed in TGF-ß1-treated cells, including control cells and RNAi-NC infection cells. As for the cells infected with RNAi-Smad4, p16 expression was not affected significantly, indicating that the up-regulation effect of TGF-ß1 on p16 expression was blocked by Smad4 silencing. As shown in Fig. 4B , unlike p16, the expression of p21 in each group was not regulated by Smad4 silencing when cells were stimulated by TGF-ß1 or not.
Lentiviral-mediated Smad4 RNAi-induced apoptosis.
We studied the effect of lentiviral-mediated Smad4 RNAi on apoptosis of SMMC-7721 cells. Apoptosis analysis was measured by PI staining and TUNEL assay. As shown in Fig. 4 , infection with LV-RNAi-Smad4 caused significant apoptosis when cells were treated by TGF-ß1, which suggested that TGF-ß1-induced cell apoptosis in SMMC-7721 was dependent on Smad4.
Role of lentiviral-mediated Smad4
RNAi on the expression of p53 and caspase 3. As shown in Fig. 5A , wild-type p53 was not regulated by silencing of Smad4 or TGF-ß1 stimulation in SMMC-7721 cells. These results implied that p53 should not be associated with TGF-ß1-induced apoptosis in SMMC-7721 cells. However, pre-caspase 3 was cleaved to the smaller fragment spliced-caspase 3 when Smad4 in cells were not knocked down (Fig. 5B) , suggesting that caspase 3 was activated by TGF-ß1, Smad4 RNAi could significantly inhibit activation of caspase 3. Caspase 3 should be regulated by TGF-ß1-Smad4 signaling pathway, and be involved in TGF-ß1-induced apoptosis in SMMC-7721 cells.
Discussion
At present, the role of TGF-ß1-Smad4 signaling pathway in HCC is unknown. This study aimed to study the effect of Smad4 on apoptosis and proliferation of SMMC-7721 cell line and explore the possible mechanism. RNAi against Smad4 gene was designed to knock down its expression in SMMC-7721 cells. The Smad4 shRNA lentiviral vector was constructed successfully. The lentiviral-mediated RNAi against Smad4 inhibited Smad4 expression effectively. We found that TGF-ß1 had a significant anti-proliferation effect on SMMC-7721 cells, which could be almost reversed by the Smad4 RNAi, suggesting that TGF-ß1-induced growth inhibition of SMMC-7721 cells was Smad4-dependent. Our results were consistent with a previous study on the SMMC-7721 cell line (23) . It has been well documented that cell proliferation depends on the cellular division cycles. Therefore, to investigate the cell cycle associated proteins regulated by Smad4 it is useful to explain the mechanism. TGF-ßs potently inhibits cell cycle progression at the G1 phase (1,24) , the G1 checkpoint can be viewed as a master checkpoint of the mammalian cell cycle (1,24) . Regulation of the G 1 phase of the cell cycle involves many different families of cyclins, cyclin-dependent kinases (CDKs) and cyclindependent kinase inhibitors (CKIs) (25) . p16 belongs to the INK4 family of CKIs and specifically inhibits CDK4/6 by preventing binding of the activating cyclin subunits to arrest cells in G 0 /G 1 phase (1). p21, a CKI of CIP/KIP family, unlike p16, binds to a number of cyclin/CDK complexes, inhibits kinase activities and induces cell cycle arrest at G 0 -G 1 phase (20, 21, 26) . As revealed by previous experiments, the expression of p16 and 21 were abnormal in HCC (27, 28) . Grau et al reported that p21 was downstream of Smad4 (29) , but a recent study reported that it was up-regulated in a Smad4-independent manner (30) . Hui et al reported that p16 protein was absent from 3 of 6 cell lines (50%) and 11 of 32 primary tumors (34%), but present in non-cancerous tissues, indicating that p16 is involved in hepatocarcinogenesis (20) . In this study, p16 protein was up-regulated significantly by TGF-ß1, and this effect was blocked by RNAi against Smad4. However, neither the treatment of TGF-ß1 nor the silence of Smad4 affected the expression of p21 in SMMC-7721 cells. These results suggest that p16, instead of p21, acts as a downstream gene of Smad4, participating in the signal transduction of TGF-ß1 in SMMC-7721 cells. p16 may be involved in TGF-ß1-induced cell degrowth in a Smad4-dependent manner.
TGF-ß1 has been shown to induce apoptosis in primary hepatocyte cultures and hepatoma cells in vitro as well as in the regressing liver (31) . However, the mechanism of TGF-ß1-induced apoptosis in hepatoma cells needs further study. In the present study, we found that TGF-ß1 induced SMMC-7721 cell apoptosis and this effect was reversed by Smad4 silencing, indicating that TGF-ß1-induced apoptosis was dependet on Smad4 in SMMC-7721 cells. Since it is known that wild-type p53 protein can induce cell apoptosis, and mutation of p53 was observed with a high incidence in HCC (27, 32) , the present study explored whether the wild-type p53 plays an important role in TGF-ß1-induced apoptosis. The results showed that TGF-ß1-induced apoptosis of SMMC-7721 cells was not companied with the change of wild-type p53 expression, demonstrating that p53 may not be regulated by the TGF-ß1-Smad4 signaling pathway.
Caspases, a group of homologous proteins, belong to cysteine proteases family. Caspase 3 is a downstream effector cysteine protease in the apoptotic pathway, and it is regarded as one of the main executors of apoptosis (33) . The activation of caspase 3 plays important roles in the hepatocellular carcinomas apoptosis (33, 34) . In this study, we observed that caspase 3 was activated in SMMC-7721 cells by TGF-ß1 and produced spliced caspase 3. This activation was inhibited by lentiviral-mediated Smad4 silencing. These results indicated that caspase 3 regulated by Smad4 may mediate the apoptosis of SMMC-7721 cells induced by TGF-ß1. It is possible that, as the result of Smad4 knockdown, this triggers the release of cytochrome C, leading to caspase-3 activation and finally apoptosis.
Taken together, the present study revealed that in hepatocellular carcinoma cell line SMMC-7721, TGF-ß1 induced anti-proliferation by up-regulating the expression of p16 and cellular apoptosis by activating caspase 3 in a Smad4-dependent manner. However, further studies on TGF-ß1-Smad4 signal system are required to clarify the pathogenesis and molecular mechanism of HCC. Additionally, the knock down of a specific gene using lentiviral-mediated RNAi appears to be a promising tool and strategy for analyzing endogenous gene function.
